Drug Trial Radar · NCT07861100
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
8,500
Planned (sponsor's estimate)
Start
Oct 26, 2026
Primary completion
Sep 16, 2030
Study completion Sep 16, 2030
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Oct 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical study is being conducted to evaluate the safety and effectiveness of zenagamtide in people with atherosclerotic cardiovascular disease (ASCVD) and excess body weight compared with placebo. The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have ASCVD and excess body weight. Participants will be randomly assigned by chance to receive either zenagamtide, the investigational treatment being tested, or a placebo, which contains no active medicine. Half of the participants will receive zenagamtide, and treatment assignment will be determined randomly. Zenagamtide is a new investigational medicine that is not yet available for prescription by doctors.
Conditions
- Cardiovascular Risk
- Obesity
Interventions
ZenagamtideDrug
Zenagamtide will be administered subcutaneously.
PlaceboDrug
Placebo will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from randomization to first occurrence of a 4-point (P) composite major adverse cardiovascular events (MACE) endpoint consisting of: Cardiovascular (CV) death, Non-fatal MI, Non-fatal stroke, HF hospitalization or urgent HF visitTime frame: From baseline (week 0) to up to 203 weeks or longer
Locations
769 sites in 26 countries. Site status is shown where the registry gives one.
Uni of Alabama at Birmingham
Birmingham, Alabama
Eastern Shore Rsrch Inst, LLC
Fairhope, Alabama
Mobile Heart Specialists
Mobile, Alabama
Chambliss Clinical Trials LLC
Montgomery, Alabama
Mercy Gilbert Medical Center
Gilbert, Arizona
Sun City Clinical Research
Glendale, Arizona
Honor Health
Scottsdale, Arizona
Clinical Research Institute of Arizona
Surprise, Arizona
National Heart Institute Cal
Beverly Hills, California
California Inst Of Renal Res
Chula Vista, California
Valley Clinical Trials
Covina, California
First Valley Medical Group
Lancaster, California
Torrance Clin Res Inst, Inc.
Lomita, California
Pacific Clinical Studies
Los Alamitos, California
Academic Medical Research Institute
Los Angeles, California
Valley Clinical Trials, Inc.
Northridge, California
Desert Oasis Hlthcr Med Group
Palm Springs, California
Clinical Trials Research_Sacramento
Sacramento, California
Paradigm Clinical Research
San Diego, California
N America Res Inst - San Dimas
San Dimas, California
Fomat Medical Research
Santa Maria, California
Bridgeport Hospital
Bridgeport, Connecticut
Innovative Research of W FL
Clearwater, Florida
Nature Coast Clin Rsrch_Crystal River
Crystal River, Florida
Florida Premier Cardiology
Delray Beach, Florida
Encore Medical Research LLC
Hollywood, Florida
Est Cst Inst for Rsrch,Jksnvil
Jacksonville, Florida
Jacksonville Ctr Clin Res
Jacksonville, Florida
Clinical Research of Cent FL
Lakeland, Florida
K2 Medical Research
Maitland, Florida
Life Spring Research Foundation LLC
Miami, Florida
Flourish Research - North Miami
Miami, Florida
Oceane 7 Medical & Research Center, Inc.
Miami, Florida
San Marcus Res Clin Miami Lakes
Miami Lakes, Florida
Advance Rsch for Hlth Improvement_Naples
Naples, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
Ocala Cardiovascular Research
Ocala, Florida
Oviedo Medical Research, LLC
Oviedo, Florida
Cardio Partners Clin Res Inst
Palm Beach Gardens, Florida
Suncoast Clinical Research, Inc.
Palm Harbor, Florida
Showing 40 of 769 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.